Stemline Therapeutic (STML)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 335 | 71 | 0 | 0 | 0 |
| Gross Profit | 335 | 71 | N/A | N/A | N/A |
| Operating Expenses | 29,325 | 24,051 | 6,468 | 2,717 | 2,260 |
| Operating Income | -28,990 | -23,980 | -6,468 | -2,717 | -2,260 |
| Interest Expense | 0 | 517 | 119 | 99 | 70 |
| Other Income | 160 | 300 | 312 | 61 | 528 |
| Pre-tax Income | -28,830 | -24,197 | -6,275 | -2,755 | -1,801 |
| Net Income Continuous | -28,830 | -24,197 | -6,275 | -2,755 | -1,801 |
| Net Income | $-28,830 | $-24,197 | $-6,275 | $-2,755 | $-1,801 |
| EPS Basic Total Ops | -2.23 | -2.35 | -1.82 | -0.80 | 3.07 |
| EPS Basic Continuous Ops | -2.23 | -2.35 | -1.82 | -0.80 | -0.55 |
| EPS Diluted Total Ops | -2.23 | -2.35 | -1.82 | -0.80 | 2.81 |
| EPS Diluted Continuous Ops | -2.23 | -2.35 | -1.82 | -0.80 | -0.50 |
| EPS Diluted Before Non-Recurring Items | -2.23 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-28,587 | $-23,903 | $-6,468 | $-2,717 | $-2,260 |